Number of substance abuse treatment facilities offering all three MAT services (Buprenorphine, Methadone, Naltrexone). Data are from The National Survey of Substance Abuse Treatment Facilities (N-SSATS) - an annual survey of U.S. facilities offering treatment services for alcohol and drug abuse. To qualify as providing all three MAT services, facilities must have declared that methadone, buprenorphine, and naltrexone are included in their programs. These include facilities coded with: At least one of: BM (Buprenorphin maintenance), BMW (Buprenorphine maintenance for a pre-determined time), BU (Buprenorphine used in treatment), BUM (Buprenorphine maintenance (<2016)), DB (Buprenorphine detoxification); At least one of: DM (Methadone detoxification), METH (Methadone), MM (Methadone maintenance), MMW (Methandone maintenance for pre-determined time); and at least one of: VTRL (Extended-release, injectable naltrexone). Of note, N-SSATS facilities can also be coded as UBN (Prescribes/administers buprenorphine and/or naltrexone). Some facilities do report as UBN but do not individually report offering either buprenorphine or naltrexone. These facilities are included in substance abuse facilities offering any MAT, but are excluded here. Data for the most recent year are downloaded from https://findtreatment.samhsa.gov/. Data for prior years are sourced from published facility directories.

Data Source: Substance Abuse and Mental Health Services Administration.

Available at: https://wwwdasis.samhsa.gov/dasis2/nssats.htm